|
Volumn 47, Issue 6, 2001, Pages 1039-1045
|
Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP.
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN RECEPTOR;
ANTINEOPLASTIC AGENT;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
EPIDERMAL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FINASTERIDE;
GROWTH INHIBITOR;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PTGS1 PROTEIN, HUMAN;
PTGS2 PROTEIN, HUMAN;
ARTICLE;
CELL CULTURE;
CELL DIVISION;
CELL SURVIVAL;
COMPARATIVE STUDY;
CYTOLOGY;
DOSE RESPONSE;
DRUG EFFECT;
ENZYMOLOGY;
EPITHELIUM CELL;
HUMAN;
MALE;
METABOLISM;
PATHOLOGY;
PHYSIOLOGY;
PROSTATE;
PROSTATE TUMOR;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
CELL SURVIVAL;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EPIDERMAL GROWTH FACTOR;
EPITHELIAL CELLS;
FINASTERIDE;
GROWTH INHIBITORS;
HUMANS;
ISOENZYMES;
MALE;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROSTATE;
PROSTATIC NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTORS, ANDROGEN;
TUMOR CELLS, CULTURED;
|
EID: 20244378920
PISSN: 01455680
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|